Confronto

Plecanatid vs. Sincalide

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

467426-54-6

25126-32-3

Peso molecolare

1682 g/mol

1143.29 g/mol

Emivita

nessun dato

Sequenza

nessun dato

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

Meccanismo d'azione

Plecanatid

Plecanatide is structurally analogous to the body's own uroguanylin and, like it, activates the GC-C receptor at the gut surface, raising cGMP and fluid secretion. Its pH-dependent activity shifts the effect toward the proximal small intestine.

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Plecanatid	Sincalide
Germania	Non approvato	Non chiaro
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Plecanatid and Sincalide?: Plecanatid is classified as "Ricerca (altro)", while Sincalide is classified as "Ricerca (altro)". Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Plecanatid or Sincalide?: The highest available evidence level is "RCT sull'uomo" for Plecanatid and "Studio sull'uomo" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Plecanatid and Sincalide in Germany and the United States?: Germania: Plecanatid — Non approvato, Sincalide — Non chiaro. Stati Uniti: Plecanatid — Su prescrizione, Sincalide — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Plecanatid

Sincalide

Germania

Non approvato

Non chiaro

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Plecanatid and Sincalide?

Plecanatid is classified as "Ricerca (altro)", while Sincalide is classified as "Ricerca (altro)". Plecanatid: Plecanatide is a 16-amino-acid analog of the body's own uroguanylin and a guanylate cyclase-C (GC-C) agonist. It is approved for chronic idiopathic constipation (CIC) and IBS with constipation (IBS-C). Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Plecanatid or Sincalide?

The highest available evidence level is "RCT sull'uomo" for Plecanatid and "Studio sull'uomo" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Plecanatid and Sincalide in Germany and the United States?

Germania: Plecanatid — Non approvato, Sincalide — Non chiaro. Stati Uniti: Plecanatid — Su prescrizione, Sincalide — Su prescrizione. These are factual summaries with source and review date on the individual pages.